{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-046502","form_type":"8-K","ticker":"VREOF","cik":"0001771706","company_name":"Vireo Growth Inc.","filed_at":"2025-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.651921+00:00","generated_at":"2026-05-22T01:57:44.673762+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Vireo Growth Q1 revenue $24.5M (+1.9% YoY); Adjusted EBITDA $6.6M (+8.5%); merger close expected Q2","bullets":["GAAP revenue $24.5M (+1.9% YoY); gross profit margin 50.6% (flat YoY).","Operating income $2.0M (-58.5% YoY); Adjusted EBITDA $6.6M (+8.5%, margin 26.8%).","Cash $86.3M; 472M shares outstanding at $0.45 per share (treasury method).","Merger transactions expected to close in Q2 2025; shareholder approvals and Utah regulatory approvals obtained.","Growth in Maryland; stable Minnesota; NY medical declined but adult-use sales commenced from indoor facility."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-046502","json":"https://secwatch.observer/filing/0001104659-25-046502.json","markdown":"https://secwatch.observer/filing/0001104659-25-046502.md","text":"https://secwatch.observer/filing/0001104659-25-046502.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1771706/000110465925046502/0001104659-25-046502-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1771706/000110465925046502/tm2514473d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T01:57:44.673762+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}